Patent · US Active

Composition comprising at least one nucleosidic moiety as a therapeutic agent, and CKC

US7834172B2 · kind B2 · utility

0Cited by

1References

18Claims

0Family size

Assignee

Novagali Pharma SA · FR

Inventors

Gregory Lambert · Rouen, FR
Frederic Lallemand · Fresnes, FR

Key dates

Filing date	Nov 14, 2007
Grant date	Nov 16, 2010
Priority date	—
Expiry date	May 3, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/006
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Composition comprising at least one nucleosidic moiety and cetalkonium chloride and pharmaceutical use thereof for prevention, treatment or relief of eye, lung, and/or respiratory tract conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.